½ÃÀ庸°í¼­
»óǰÄÚµå
1388473

µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : ¼ºÀå, Àü¸Á, °æÀï ºÐ¼®(2023-2031³â)

Veterinary Supplements Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Acute Market Reports | ÆäÀÌÁö Á¤º¸: ¿µ¹® 118 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µ¿¹° ÇコÄɾîÀÇ Áß¿äÇÑ ¿ä¼ÒÀÎ µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀåÀº 2023-2031³âÀÇ ¿¹Ãø ±â°£ Áß CAGR 7%ÀÇ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ´Ù¾çÇÑ À¯ÇüÀÇ º¸ÃæÁ¦°¡ Æ÷ÇÔµÇ¸ç ¹Ý·Áµ¿¹°°ú °¡Ãà ¸ðµÎ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ¸î °¡Áö ÃËÁø¿äÀΰú ÇÑ °¡Áö Áß¿äÇÑ ¾ïÁ¦¿äÀÎÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀåÀº 2023-2031³â ´Ù¾çÇÑ º¸ÃæÁ¦ À¯Çü, µ¿¹° À¯Çü, Áö¿ªÀû Ãß¼¼¿¡ µû¶ó ¾ÈÁ¤ÀûÀÎ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±ÔÁ¦ À̽´°¡ ÁÖ¿ä ÀúÇØ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, ±ÔÁ¤ Áؼö ¹× ¾ÈÀü Á¶Ä¡ÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. °æÀï µ¿ÇâÀº ÁÖ¿ä ±â¾÷ÀÌ ÀÌ ¿ªµ¿ÀûÀ̰í ÁøÈ­ÇÏ´Â »ê¾÷¿¡¼­ Çõ½Å, ÆÄÆ®³Ê½Ê, ¼¼°è ÁøÃâ¿¡ °è¼Ó ÁýÁßÇÒ °ÍÀÓÀ» ½Ã»çÇÕ´Ï´Ù.

Ç×»êÈ­Á¦, µ¿¹°ÀÇ °Ç°­ ÁõÁøÀ» ÃËÁø

Ç×»êÈ­Á¦´Â 2022³â µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀåÀÇ µÎµå·¯Áø ÃËÁø¿äÀÎÀ¸·Î ºÎ»óÇϰí 2023-2031³â ±× Á߿伺À» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºñŸ¹Î C¿Í E, ¼¿·¹´½, ÄÚ¿£ÀÚÀÓ Q10À» Æ÷ÇÔÇÑ Ç×»êÈ­ º¸ÃæÁ¦´Â µ¿¹°ÀÇ °Ç°­À» Áö¿øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. »êÈ­ ½ºÆ®·¹½º¿Í ½Î¿ì°í ¹Ý·Áµ¿¹°°ú °¡ÃàÀÇ ¸¸¼ºÁúȯÀÇ À§ÇèÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀ» ÁÖ¸ç, 2022³â ÀÌ ºÎ¹®ÀÇ »ó´çÇÑ ¸ÅÃâÀº µ¿¹° °Ç°­ ÁõÁø¿¡ ´ëÇÑ Ç×»êÈ­Á¦ÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚ¿Í °¡Ãà »ý»êÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁ³À½À» ¹Ý¿µÇÕ´Ï´Ù. ¶ÇÇÑ Ç×»êÈ­Á¦ ºÎ¹®Àº µ¿¹° ¿¹¹æ ÀÇ·á Á¶Ä¡ÀÇ Ã¤Åà Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°¡Ãà ¿µ¾ç¿¡ ´ëÇÑ Á߿伺 Áõ°¡

2022³â Ãà»ê ºÐ¾ß´Â µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¸ÅÃâÀ» ¿Ã·ÈÀ¸¸ç, ÀÌ·¯ÇÑ Ãß¼¼´Â 2031³â±îÁö Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ÁÖ·Î °íǰÁú À°·ù ¹× À¯Á¦Ç°¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ °¡Ãà »ý»êÀÚµéÀº °¡ÃàÀÇ ¿µ¾ç°ú °Ç°­À» °³¼±ÇÏ´Â µ¥ Á¡Á¡ ´õ ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ºñŸ¹Î, ´Ü¹éÁú, ¾Æ¹Ì³ë»êÀ» Æ÷ÇÔÇÑ °¡Ãà¿ë º¸ÃæÁ¦´Â ÀÌ·¯ÇÑ ¸ñÇ¥¸¦ ´Þ¼ºÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. Ãà»ê ºÐ¾ß´Â µ¿¹°ÀÇ ¿µ¾ç°ú »ý»ê È¿À²À» ÃÖÀûÈ­Çϱâ À§ÇÑ ³ó°¡¿Í ¸ñÀåÁÖµéÀÇ Áö¼ÓÀûÀÎ ³ë·ÂÀ¸·Î ¿¹Ãø ±â°£ Áß »ó´çÇÑ CAGRÀ» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ý·Áµ¿¹°ÀÇ À£ºù°ú ÇÁ·Î¹ÙÀÌ¿Àƽ½ºÀÇ ¿ªÇÒ

ÇÁ·Î¹ÙÀÌ¿Àƽ½º´Â 2022³â µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î °¢±¤¹Þ°í Àִµ¥, ±× ÁÖ¿ä ÀÌÀ¯´Â ¹Ý·Áµ¿¹°ÀÇ °Ç°­À» ÁõÁø½ÃŰ´Â ¿ªÇÒÀ» Çϱ⠶§¹®ÀÔ´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º º¸ÃæÁ¦´Â ¹Ý·Áµ¿¹°ÀÇ ¼ÒÈ­±â °Ç°­¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ±ÕÇü ÀâÈù Àå³» ¼¼±ÕÃÑÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° »çÀ° Æ®·»µå Áõ°¡¿Í ¹Ý·Áµ¿¹° ¿µ¾çÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÇÁ·Î¹ÙÀÌ¿Àƽ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ »ç¶ûÇÏ´Â µ¿¹°ÀÇ Àü¹ÝÀûÀÎ °Ç°­°ú À£ºùÀ» ÃÖ¿ì¼± ¼øÀ§·Î »ï°í ÀÖÀ¸¹Ç·Î ÀÌ ºÐ¾ß´Â ¿¹Ãø ±â°£(2023-2031³â) µ¿¾È °ß°íÇÑ CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

µ¿¹°¿ë º¸Á¶Á¦ ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

À¯¸ÁÇÑ ¼ºÀå¿¡µµ ºÒ±¸Çϰí, µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀåÀÇ Áß¿äÇÑ ¾ïÁ¦¿äÀÎ Áß Çϳª´Â Á¦Ç°ÀÇ ¾ÈÀü¼º°ú È¿´É¿¡ ´ëÇÑ ±ÔÁ¦ ¹®Á¦¿Í ¿ì·ÁÀÔ´Ï´Ù. ¼¼°è Á¤ºÎ ¹× ±ÔÁ¦±â°üÀº µ¿¹° ÇコÄÉ¾î »ê¾÷¿¡¼­ º¸ÃæÁ¦ Á¦Á¶¾÷üÀÇ ÁÖÀåÀ» Á¡Á¡ ´õ ¸é¹ÐÈ÷ Á¶»çÇß½À´Ï´Ù. º¸ÃæÁ¦°¡ ¿ä±¸µÇ´Â ǰÁú ±âÁØÀ» ÃæÁ·ÇÏ°í µ¿¹°¿¡°Ô ±â´ëµÇ´Â ÇýÅÃÀ» Á¦°øÇÏ´ÂÁö È®ÀÎÇÏ´Â °ÍÀº º¹ÀâÇϰí ÁøÈ­ÇÏ´Â °úÁ¤ÀÔ´Ï´Ù. ±ÔÁ¦ ȯ°æÀº ½Å±Ô ÁøÃâ±â¾÷¿¡°Ô´Â ½ÃÀå ÁøÀÔ À庮ÀÌ µÉ ¼ö ÀÖÀ¸¸ç, ±ÔÁ¤ Áؼö ¹®Á¦°¡ ¹ß»ýÇϸé Á¦Ç° ȸ¼ö ¹× ÆÇ¸Å Áß´ÜÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ¾÷°è ÀÌÇØ°ü°èÀÚµéÀº ÀÌ·¯ÇÑ Á¦¾àÀ» È¿°úÀûÀ¸·Î ±Øº¹Çϰí Á¦Ç°ÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ ¾ö°ÝÇÑ R&D, ÀÓ»ó½ÃÇè ¹× ±ÔÁ¤ Áؼö Á¶Ä¡¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù.

°Ç°­º¸Á¶½ÄǰÀ¯Çüº° ½ÃÀå ¼¼ºÐÈ­: Ç×»êÈ­Á¦ ºÎ¹®ÀÌ ½ÃÀåÀ» µ¶Á¡

2022³â µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¸ÅÃâÀ» âÃâÇÑ ºÎ¹®Àº Ç×»êÈ­Á¦ ºÎ¹®ÀÔ´Ï´Ù. ºñŸ¹Î C¿Í E, ¼¿·¹´½, ÄÚ¿£ÀÚÀÓ Q10À» Æ÷ÇÔÇÑ Ç×»êÈ­ º¸ÃæÁ¦´Â ¹Ý·Áµ¿¹°°ú °¡ÃàÀÇ »êÈ­ ½ºÆ®·¹½º¿¡ ´ëÀÀÇÏ°í ¸¸¼ºÁúȯÀÇ À§ÇèÀ» ÁÙÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â 2031³â±îÁö Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Ç×»êÈ­Á¦ ºÐ¾ß°¡ °¡Àå ³ôÀº ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹»ó ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¹Ý·Áµ¿¹°°ú °¡ÃàÀÇ À£ºù Æ®·»µå Áõ°¡¿Í ÇÔ²² µ¿¹°ÀÇ ¿¹¹æÀû °Ç°­°ü¸® ´ëÃ¥ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

µ¿¹° À¯Çüº° ½ÃÀå ¼¼ºÐÈ­: Ãà»ê ºÎ¹®ÀÌ ½ÃÀåÀ» µ¶Á¡

2022³â µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀåÀº Ãà»ê ºÎ¹®ÀÌ ¸ÅÃâ°ú ¼ºÀ强 Ãø¸é¿¡¼­ ¼±µÎ¸¦ ´Þ¸®°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº °íǰÁú À°·ù ¹× À¯Á¦Ç°¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ °¡Ãà »ý»êÀÚµéÀº °¡ÃàÀÇ ¿µ¾ç°ú °Ç°­À» °³¼±Çϱâ À§ÇØ Á¡Á¡ ´õ ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸¸ç, ÀÌ´Â ºñŸ¹Î, ´Ü¹éÁú ¹× ¾Æ¹Ì³ë»êÀ» Æ÷ÇÔÇÑ °¡Ãà º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÎ¹®Àº µ¿¹°ÀÇ ¿µ¾ç°ú »ý»ê È¿À²À» ÃÖÀûÈ­Çϱâ À§ÇÑ Áö¼ÓÀûÀÎ ³ë·Â¿¡ ÈûÀÔ¾î 2023-2031³â ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ Ãà»ê ºÎ¹®Àº ¿¹Ãø ±â°£ Áß »ó´çÇÑ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

APACÀº ¼¼°è ¸®´õ¸¦ À¯Áö

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ¿¹Ãø ±â°£(2023-2031³â) µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ¹Ý·Áµ¿¹°ÀÇ °Ç°­°ú À£ºù¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÇÁ¸®¹Ì¾ö ¹Ý·Áµ¿¹° º¸Á¶Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Ç߱⠶§¹®ÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç, ƯÈ÷ Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡µéÀº 2022³â¿¡µµ °¡Àå ³ôÀº ¸ÅÃâ ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌµé ±¹°¡¿¡¼­´Â °¡Ã³ºÐ ¼Òµæ Áõ°¡, µµ½ÃÈ­, Áß»êÃþ Áõ°¡·Î ÀÎÇØ µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯·´Àº µ¿¹° º¹Áö¿Í ÷´ÜÈ­µÈ ¼öÀÇÇÐ ÀÇ·á¿¡ ´ëÇÑ ³ë·ÂÀ» ¹Ý¿µÇÏ¿© ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

½ÃÀå °æÀïÀº ¿¹Ãø ±â°£ Áß °ÝÈ­

2022³â, µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀåÀº ÁÖ¿ä ±â¾÷°£ Ä¡¿­ÇÑ °æÀïÀ» ¸ñ°ÝÇß½À´Ï´Ù. Zoetis Inc., Nutramax Laboratories, Vetoquinol S.A., Ceva Sante Animale, Elanco Animal Health, Dechra Pharmaceuticals plc, Merck Animal Health, Virbac S.A., Boehringer Ingelheim, Norbrook Laboratories Limited, Hester Biosciences Limited, Merial Animal Health Limited, Novartis Animal Health, Inc., Nutreco N.V., Ouro Fino Saúde Animal µîÀÇ ±â¾÷ÀÌ ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¾÷°è ´ë±â¾÷Àº Á¦Ç° ´Ù¾çÈ­, µ¿¹°º´¿ø°úÀÇ Àü·«Àû Á¦ÈÞ, ½ÅÈï ½ÃÀåÀ¸·ÎÀÇ ÁøÃâ µîÀÇ Àü·«¿¡ ÁÖ·ÂÇϸç, ½ÃÀå ¿ìÀ§¼ºÀ» À¯ÁöÇϰí ÀÖ½À´Ï´Ù. 2023-2031³âÀÇ ¿¹Ãø ±â°£À¸·Î À̵¿ÇÏ¿© ÀÌ ±â¾÷Àº °è¼Ó ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí, µ¿¹° °íÀ¯ ¿ä±¸¿¡ ´ëÀÀÇÑ Çõ½ÅÀû¡¤Æ¯¼öÇÑ º¸ÃæÁ¦¸¦ ÅõÀÔÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ µðÁöÅÐ ¸¶ÄÉÆÃ°ú E-Commerce ä³ÎÀ» Ȱ¿ëÇÏ¿© º¸´Ù ±¤¹üÀ§ÇÑ °í°´Ãþ¿¡ µµ´ÞÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. Á¦Ç° ¾ÈÀü¼º°ú À¯È¿¼ºÀ» È®º¸ÇÏ´Â ÇÑÆí, õ¿¬ ¼ÒÀç ¹× ¿À°¡´Ð º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼ö¿ä º¯È­¿¡ ´ëÀÀÇÏ´Â °Í¿¡ ¾ÕÀ¸·Îµµ ÃÊÁ¡À» ¸ÂÃâ °ÍÀ¸·Î »ý°¢µË´Ï´Ù

¸ñÂ÷

Á¦1Àå ¼­¹®

  • ¸®Æ÷Æ® ³»¿ë
    • º¸°í¼­ÀÇ ¸ñÀû
    • ´ë»óÀÚ
    • ÁÖ¿ä Á¦°ø »óǰ
  • ½ÃÀå ¼¼ºÐÈ­
  • Á¶»ç ¹æ¹ý
    • ´Ü°è I - 2Â÷ Á¶»ç
    • ´Ü°è II - 1Â÷ Á¶»ç
    • ´Ü°è III - Àü¹®°¡ ÆÐ³Î ¸®ºä
    • ÀüÁ¦Á¶°Ç
    • äÅÃÇÑ ¾îÇÁ·ÎÄ¡

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : °æÀï ºÐ¼®

  • ÁÖ¿ä º¥´õÀÇ ½ÃÀå Æ÷Áö¼Å´×
  • º¥´õ°¡ äÅÃÇÏ´Â Àü·«
  • ÁÖ¿ä »ê¾÷ Àü·«
  • Tier ºÐ¼® : 2022 vs 2031

Á¦4Àå µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : °Å½ÃÀû ºÐ¼®°ú ½ÃÀå ¿ªÇÐ

  • ¼­·Ð
  • ¼¼°èÀÇ µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå ±Ý¾× 2021-2031
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ÁÖ¿ä °úÁ¦
    • ÁÖ¿ä ±âȸ
  • ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®
  • ½Ã¼Ò ºÐ¼®

Á¦5Àå µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : º¸ÃæÁ¦ÀÇ À¯Çüº° 2021-2031

  • ½ÃÀå °³¿ä
  • ¼ºÀ塤¸ÅÃ⠺м® : 2022 vs 2031
  • ½ÃÀå ¼¼ºÐÈ­
    • Ç×»êÈ­¹°Áú
    • ºñŸ¹Î
    • ´Ü¹éÁú¡¤¾Æ¹Ì³ë»ê
    • È¿¼Ò
    • ÇÁ·Î¹ÙÀÌ¿Àƽ½º
    • Çʼö Áö¹æ»ê
    • ±âŸ

Á¦6Àå µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : µ¿¹° À¯Çüº° 2021-2031

  • ½ÃÀå °³¿ä
  • ¼ºÀ塤¸ÅÃ⠺м® : 2022 vs 2031
  • ½ÃÀå ¼¼ºÐÈ­
    • ¹Ý·Áµ¿¹°
      • °³
      • °í¾çÀÌ
    • °¡Ãà
      • ¼Ò
      • ¸»
      • ¾ç
      • ±âŸ

Á¦7Àå µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : ¿ëµµº°/ÀÌÁ¡ ºÐ¾ßº° 2021-2031

  • ½ÃÀå °³¿ä
  • ¼ºÀ塤¸ÅÃ⠺м® : 2022 vs 2031
  • ½ÃÀå ¼¼ºÐÈ­
    • °üÀý °Ç°­ Áö¿ø
    • ÁøÁ¤/½ºÆ®·¹½º/ºÒ¾È
    • ¼ÒÈ­±â °Ç°­
    • ¿¡³ÊÁö¿Í ÀüÇØÁú
    • ¸é¿ª Áö¿ø
    • ÇÇºÎ¿Í ÇǸð °Ç°­
    • ±âŸ

Á¦8Àå µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Á¦Çüº° 2021-2031

  • ½ÃÀå °³¿ä
  • ¼ºÀ塤¸ÅÃ⠺м® : 2022 vs 2031
  • ½ÃÀå ¼¼ºÐÈ­
    • ÇÊ¡¤Á¤Á¦
    • Ãò¾îºí
    • ºÐ¸»
    • ±âŸ

Á¦9Àå µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : À¯Åë ä³Îº° 2021-2031

  • ½ÃÀå °³¿ä
  • ¼ºÀ塤¸ÅÃ⠺м® : 2022 vs 2031
  • ½ÃÀå ¼¼ºÐÈ­
    • ¼ÒÇü µ¿¹° ¼öÀÇ
    • ´ëÇü µ¿¹° ¼öÀÇ
    • È¥ÇÕ µ¿¹° ¼öÀÇ
    • ¼Ò¸ÅÁ¡
    • µå·¯±×½ºÅä¾î
    • ¿Â¶óÀÎ ÆÇ¸Å

Á¦10Àå ºÏ¹ÌÀÇ µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå 2021-2031

  • ½ÃÀå °³¿ä
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : º¸ÃæÁ¦ÀÇ À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : µ¿¹° À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : ¿ëµµº°/ÀÌÁ¡ ºÐ¾ßº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Á¦Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : À¯Åë ä³Îº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Áö¿ªº° 2021-2031
    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
      • ±âŸ ºÏ¹Ì Áö¿ª

Á¦11Àå ¿µ±¹°ú À¯·´¿¬ÇÕÀÇ µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå 2021-2031

  • ½ÃÀå °³¿ä
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : º¸ÃæÁ¦ÀÇ À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : µ¿¹° À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : ¿ëµµº°/ÀÌÁ¡ ºÐ¾ßº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Á¦Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : À¯Åë ä³Îº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Áö¿ªº° 2021-2031
    • ¿µ±¹°ú À¯·´¿¬ÇÕ
      • ¿µ±¹
      • µ¶ÀÏ
      • ½ºÆäÀÎ
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ±âŸ À¯·´ Áö¿ª

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå 2021-2031

  • ½ÃÀå °³¿ä
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : º¸ÃæÁ¦ÀÇ À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : µ¿¹° À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : ¿ëµµº°/ÀÌÁ¡ ºÐ¾ßº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Á¦Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : À¯Åë ä³Îº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Áö¿ªº° 2021-2031
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç

Á¦13Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå 2021-2031

  • ½ÃÀå °³¿ä
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : º¸ÃæÁ¦ÀÇ À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : µ¿¹° À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : ¿ëµµº°/ÀÌÁ¡ ºÐ¾ßº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Á¦Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : À¯Åë ä³Îº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Áö¿ªº° 2021-2031
    • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« Áö¿ª

Á¦14Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå 2021-2031

  • ½ÃÀå °³¿ä
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : º¸ÃæÁ¦ÀÇ À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : µ¿¹° À¯Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : ¿ëµµº°/ÀÌÁ¡ ºÐ¾ßº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Á¦Çüº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : À¯Åë ä³Îº° 2021-2031
  • µ¿¹°¿ë º¸ÃæÁ¦ ½ÃÀå : Áö¿ªº° 2021-2031
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
      • GCC
      • ¾ÆÇÁ¸®Ä«
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦15Àå ±â¾÷ °³¿ä

  • Zoetis Inc.
  • Nutramax Laboratories
  • Vetoquinol S.A
  • Ceva Sante Animale
  • Elanco Animal Health
  • Dechra Pharmaceuticals plc
  • Merck Animal Health
  • Virbac S.A.
  • Boehringer Ingelheim
  • Norbrook Laboratories Limited
  • Hester Biosciences Limited
  • Merial Animal Health Limited
  • Novartis Animal Health Inc.
  • Nutreco N.V.
  • Ouro Fino SaAºde Animal
  • ±âŸ ÁÖ¿ä ±â¾÷
KSA 23.12.13

The veterinary supplements market, a critical component of animal healthcare, is poised for a CAGR of 7% during the forecast period of 2023 to 2031. This market encompasses various supplement types and serves both companion animals and livestock. It is influenced by several driving factors and one significant restraint. The veterinary supplements market is set for steady growth from 2023 to 2031, driven by various supplement types, animal types, and geographic trends. Regulatory challenges pose a significant restraint, emphasizing the need for compliance and safety measures. Competitive trends suggest that key players will continue to focus on innovation, partnerships, and global expansion in this dynamic and evolving industry.

Antioxidants Boost Animal Wellness

Antioxidants emerged as a prominent driver in the veterinary supplements market in 2022 and are expected to maintain their significance from 2023 to 2031. Antioxidant supplements, including vitamins C and E, selenium, and coenzyme Q10, play a crucial role in supporting animal wellness. They help combat oxidative stress and reduce the risk of chronic diseases in both companion animals and livestock. The segment's substantial revenue in 2022 reflects the growing awareness among pet owners and livestock producers about the benefits of antioxidants in enhancing animal health. Moreover, the antioxidant segment is projected to exhibit the highest Compound Annual Growth Rate (CAGR) during the forecast period, driven by the increasing adoption of preventive healthcare measures for animals.

Growing Emphasis on Livestock Nutrition

In 2022, the Livestock segment garnered the highest revenue in the veterinary supplements market, a trend expected to persist through 2031. This growth is primarily attributed to the rising global demand for high-quality meat and dairy products. To meet this demand, livestock producers are increasingly focusing on improving the nutrition and health of their animals. Livestock supplements, including vitamins, proteins, and amino acids, are integral to achieving these goals. The Livestock segment is projected to maintain a substantial CAGR during the forecast period, driven by the continuous efforts of farmers and ranchers to optimize animal nutrition and production efficiency.

Companion Animal Wellness and the Role of Probiotics

Probiotics gained prominence as drivers in the veterinary supplements market in 2022, primarily due to their role in enhancing the wellness of companion animals. Probiotic supplements are recognized for their positive effects on the digestive health of pets, helping to maintain a balanced gut microbiome. The rising pet ownership trend, coupled with a growing awareness of the importance of pet nutrition, fueled the demand for probiotics. The segment is anticipated to exhibit a robust CAGR during the forecast period (2023 to 2031) as pet owners continue to prioritize the overall health and well-being of their beloved animals.

Restraint in the Veterinary Supplements Market

Despite the promising growth, one significant restraint in the veterinary supplements market is regulatory challenges and concerns regarding product safety and efficacy. Governments and regulatory bodies worldwide are increasingly scrutinizing the claims made by supplement manufacturers in the animal healthcare industry. Ensuring that supplements meet the required quality standards and that they deliver the expected benefits to animals is a complex and evolving process. The regulatory landscape can be a barrier to market entry for new players and can also lead to product recalls or discontinuations if compliance issues arise. Industry stakeholders need to invest in rigorous research and development, clinical trials, and compliance measures to navigate this restraint effectively and ensure the safety and efficacy of their products.

Market Segmentation by Supplement Type: Antioxidants Segment Dominates the Market

In 2022, within the Veterinary Supplements Market, the highest revenue was generated by the Antioxidants segment, reflecting the growing awareness of their benefits in animal health. Antioxidant supplements, including vitamins C and E, selenium, and coenzyme Q10, play a crucial role in combating oxidative stress and reducing the risk of chronic diseases in both companion animals and livestock. This dominance is expected to continue through 2031, with the Antioxidants segment projected to exhibit the highest Compound Annual Growth Rate (CAGR). The anticipated growth is driven by the increasing adoption of preventive healthcare measures for animals, aligning with the growing trend of pet and livestock wellness.

Market Segmentation by Animal Type: Livestock Segment Dominates the Market

The Livestock segment led the Veterinary Supplements Market in terms of both revenue and growth potential in 2022. This growth is attributed to the rising global demand for high-quality meat and dairy products. To meet this demand, livestock producers are increasingly focusing on improving the nutrition and health of their animals, driving the need for livestock supplements, including vitamins, proteins, and amino acids. This segment is projected to maintain its dominance from 2023 to 2031, supported by continuous efforts to optimize animal nutrition and production efficiency. Additionally, the Livestock segment is expected to have a substantial CAGR during the forecast period.

APAC Remains as the Global Leader

In terms of geographic trends, North America is expected to exhibit the highest CAGR during the forecast period (2023 to 2031). This growth is attributed to the increasing awareness of pet health and wellness and the growing demand for premium pet supplements. The Asia-Pacific region, particularly countries like China and India, is projected to maintain its position as the region with the highest revenue percentage as it was in 2022. The rising disposable income, urbanization, and a burgeoning middle-class population in these countries contribute to the continuous growth of the veterinary supplements market. Additionally, Europe is likely to show steady growth, reflecting the region's commitment to animal welfare and advanced veterinary healthcare practices.

Market Competition to Intensify During the Forecast Period

In 2022, the veterinary supplements market witnessed intense competition among key players. Companies such as Zoetis Inc., Nutramax Laboratories, Vetoquinol S.A, Ceva Sante Animale, Elanco Animal Health, Dechra Pharmaceuticals plc, Merck Animal Health, Virbac S.A., Boehringer Ingelheim, Norbrook Laboratories Limited, Hester Biosciences Limited, Merial Animal Health Limited, Novartis Animal Health, Inc., Nutreco N.V., and Ouro Fino Saúde Animal. were among the market leaders. These industry giants focused on strategies like product diversification, strategic partnerships with veterinary clinics, and expansion into emerging markets to maintain their market dominance. As we move into the forecast period from 2023 to 2031, it is expected that these players will continue to invest in research and development to introduce innovative and specialized supplements catering to the unique needs of animals. Moreover, digital marketing and e-commerce channels are likely to be leveraged to reach a broader customer base. The focus will remain on ensuring product safety and efficacy while meeting evolving consumer demands for natural and organic supplements.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofVeterinary Supplements market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Veterinary Supplements market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Supplement Type

    • Antioxidants
    • Vitamins
    • Proteins / Amino acids
    • Enzymes
    • Probiotics
    • Essential Fatty Acids
    • Others

Animal Type

    • Companion Animals
  • Dog
  • Cat
    • Livestock
  • Cattle
  • Horse
  • Sheep
  • Others

Application / Benefit Area

    • Joint Health Support
    • Calming / Stress / Anxiety
    • Digestive Health
    • Energy & Electrolytes
    • Immunity Support
    • Skin & Coat Health
    • Others

Dosage Form

    • Pills & Tablets
    • Chewables
    • Powders
    • Others

Distribution Channel

    • Small Animal Veterinary
    • Large Animal Veterinary
    • Mixed Animal Veterinary
    • Retail Stores
    • Drug Stores
    • Online Sales

Region Segment (2021-2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Veterinary Supplements market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Veterinary Supplements market?
  • Which is the largest regional market for Veterinary Supplements market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Veterinary Supplements market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Veterinary Supplements market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Veterinary Supplements Market
  • 2.2. Global Veterinary Supplements Market, By Supplement Type, 2022 (US$ Million)
  • 2.3. Global Veterinary Supplements Market, By Animal Type, 2022 (US$ Million)
  • 2.4. Global Veterinary Supplements Market, By Application / Benefit Area, 2022 (US$ Million)
  • 2.5. Global Veterinary Supplements Market, By Dosage Form, 2022 (US$ Million)
  • 2.6. Global Veterinary Supplements Market, By Distribution Channel, 2022 (US$ Million)
  • 2.7. Global Veterinary Supplements Market, By Geography, 2022 (US$ Million)
  • 2.8. Attractive Investment Proposition by Geography, 2022

3. Veterinary Supplements Market: Competitive Analysis

  • 3.1. Market Positioning of Key Veterinary Supplements Market Vendors
  • 3.2. Strategies Adopted by Veterinary Supplements Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Veterinary Supplements Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Veterinary Supplements Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Antioxidants
    • 5.3.2. Vitamins
    • 5.3.3. Proteins / Amino acids
    • 5.3.4. Enzymes
    • 5.3.5. Probiotics
    • 5.3.6. Essential Fatty Acids
    • 5.3.7. Others

6. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Companion Animals
      • 6.3.1.1. Dog
      • 6.3.1.2. Cat
    • 6.3.2. Livestock
      • 6.3.2.1. Cattle
      • 6.3.2.2. Horse
      • 6.3.2.3. Sheep
      • 6.3.2.4. Others

7. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Joint Health Support
    • 7.3.2. Calming / Stress / Anxiety
    • 7.3.3. Digestive Health
    • 7.3.4. Energy & Electrolytes
    • 7.3.5. Immunity Support
    • 7.3.6. Skin & Coat Health
    • 7.3.7. Others

8. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Pills & Tablets
    • 8.3.2. Chewables
    • 8.3.3. Powders
    • 8.3.4. Others

9. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 9.3. Market Segmentation
    • 9.3.1. Small Animal Veterinary
    • 9.3.2. Large Animal Veterinary
    • 9.3.3. Mixed Animal Veterinary
    • 9.3.4. Retail Stores
    • 9.3.5. Drug Stores
    • 9.3.6. Online Sales

10. North America Veterinary Supplements Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
  • 10.3. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
  • 10.4. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
  • 10.5. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
  • 10.6. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
  • 10.7.Veterinary Supplements Market: By Region, 2021-2031, USD (Million)
    • 10.7.1.North America
      • 10.7.1.1. U.S.
        • 10.7.1.1.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 10.7.1.1.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 10.7.1.1.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 10.7.1.1.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 10.7.1.1.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.7.1.2. Canada
        • 10.7.1.2.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 10.7.1.2.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 10.7.1.2.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 10.7.1.2.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 10.7.1.2.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.7.1.3. Rest of North America
        • 10.7.1.3.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 10.7.1.3.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 10.7.1.3.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 10.7.1.3.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 10.7.1.3.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)

11. UK and European Union Veterinary Supplements Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
  • 11.3. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
  • 11.4. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
  • 11.5. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
  • 11.6. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
  • 11.7.Veterinary Supplements Market: By Region, 2021-2031, USD (Million)
    • 11.7.1.UK and European Union
      • 11.7.1.1. UK
        • 11.7.1.1.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 11.7.1.1.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 11.7.1.1.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 11.7.1.1.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 11.7.1.1.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 11.7.1.2. Germany
        • 11.7.1.2.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 11.7.1.2.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 11.7.1.2.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 11.7.1.2.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 11.7.1.2.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 11.7.1.3. Spain
        • 11.7.1.3.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 11.7.1.3.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 11.7.1.3.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 11.7.1.3.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 11.7.1.3.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 11.7.1.4. Italy
        • 11.7.1.4.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 11.7.1.4.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 11.7.1.4.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 11.7.1.4.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 11.7.1.4.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 11.7.1.5. France
        • 11.7.1.5.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 11.7.1.5.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 11.7.1.5.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 11.7.1.5.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 11.7.1.5.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 11.7.1.6. Rest of Europe
        • 11.7.1.6.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 11.7.1.6.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 11.7.1.6.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 11.7.1.6.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 11.7.1.6.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)

12. Asia Pacific Veterinary Supplements Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
  • 12.3. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
  • 12.4. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
  • 12.5. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
  • 12.6. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
  • 12.7.Veterinary Supplements Market: By Region, 2021-2031, USD (Million)
    • 12.7.1.Asia Pacific
      • 12.7.1.1. China
        • 12.7.1.1.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 12.7.1.1.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 12.7.1.1.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 12.7.1.1.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 12.7.1.1.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 12.7.1.2. Japan
        • 12.7.1.2.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 12.7.1.2.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 12.7.1.2.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 12.7.1.2.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 12.7.1.2.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 12.7.1.3. India
        • 12.7.1.3.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 12.7.1.3.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 12.7.1.3.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 12.7.1.3.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 12.7.1.3.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 12.7.1.4. Australia
        • 12.7.1.4.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 12.7.1.4.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 12.7.1.4.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 12.7.1.4.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 12.7.1.4.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 12.7.1.5. South Korea
        • 12.7.1.5.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 12.7.1.5.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 12.7.1.5.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 12.7.1.5.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 12.7.1.5.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 12.7.1.6. Rest of Asia Pacific
        • 12.7.1.6.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 12.7.1.6.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 12.7.1.6.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 12.7.1.6.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 12.7.1.6.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)

13. Latin America Veterinary Supplements Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
  • 13.3. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
  • 13.4. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
  • 13.5. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
  • 13.6. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
  • 13.7.Veterinary Supplements Market: By Region, 2021-2031, USD (Million)
    • 13.7.1.Latin America
      • 13.7.1.1. Brazil
        • 13.7.1.1.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 13.7.1.1.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 13.7.1.1.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 13.7.1.1.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 13.7.1.1.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 13.7.1.2. Mexico
        • 13.7.1.2.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 13.7.1.2.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 13.7.1.2.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 13.7.1.2.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 13.7.1.2.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 13.7.1.3. Rest of Latin America
        • 13.7.1.3.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 13.7.1.3.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 13.7.1.3.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 13.7.1.3.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 13.7.1.3.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)

14. Middle East and Africa Veterinary Supplements Market, 2021-2031, USD (Million)

  • 14.1. Market Overview
  • 14.2. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
  • 14.3. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
  • 14.4. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
  • 14.5. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
  • 14.6. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
  • 14.7.Veterinary Supplements Market: By Region, 2021-2031, USD (Million)
    • 14.7.1.Middle East and Africa
      • 14.7.1.1. GCC
        • 14.7.1.1.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 14.7.1.1.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 14.7.1.1.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 14.7.1.1.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 14.7.1.1.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 14.7.1.2. Africa
        • 14.7.1.2.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 14.7.1.2.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 14.7.1.2.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 14.7.1.2.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 14.7.1.2.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)
      • 14.7.1.3. Rest of Middle East and Africa
        • 14.7.1.3.1. Veterinary Supplements Market: By Supplement Type, 2021-2031, USD (Million)
        • 14.7.1.3.2. Veterinary Supplements Market: By Animal Type, 2021-2031, USD (Million)
        • 14.7.1.3.3. Veterinary Supplements Market: By Application / Benefit Area, 2021-2031, USD (Million)
        • 14.7.1.3.4. Veterinary Supplements Market: By Dosage Form, 2021-2031, USD (Million)
        • 14.7.1.3.5. Veterinary Supplements Market: By Distribution Channel, 2021-2031, USD (Million)

15. Company Profile

  • 15.1. Zoetis Inc.
    • 15.1.1. Company Overview
    • 15.1.2. Financial Performance
    • 15.1.3. Product Portfolio
    • 15.1.4. Strategic Initiatives
  • 15.2. Nutramax Laboratories
    • 15.2.1. Company Overview
    • 15.2.2. Financial Performance
    • 15.2.3. Product Portfolio
    • 15.2.4. Strategic Initiatives
  • 15.3. Vetoquinol S.A
    • 15.3.1. Company Overview
    • 15.3.2. Financial Performance
    • 15.3.3. Product Portfolio
    • 15.3.4. Strategic Initiatives
  • 15.4. Ceva Sante Animale
    • 15.4.1. Company Overview
    • 15.4.2. Financial Performance
    • 15.4.3. Product Portfolio
    • 15.4.4. Strategic Initiatives
  • 15.5. Elanco Animal Health
    • 15.5.1. Company Overview
    • 15.5.2. Financial Performance
    • 15.5.3. Product Portfolio
    • 15.5.4. Strategic Initiatives
  • 15.6. Dechra Pharmaceuticals plc
    • 15.6.1. Company Overview
    • 15.6.2. Financial Performance
    • 15.6.3. Product Portfolio
    • 15.6.4. Strategic Initiatives
  • 15.7. Merck Animal Health
    • 15.7.1. Company Overview
    • 15.7.2. Financial Performance
    • 15.7.3. Product Portfolio
    • 15.7.4. Strategic Initiatives
  • 15.8. Virbac S.A.
    • 15.8.1. Company Overview
    • 15.8.2. Financial Performance
    • 15.8.3. Product Portfolio
    • 15.8.4. Strategic Initiatives
  • 15.9. Boehringer Ingelheim
    • 15.9.1. Company Overview
    • 15.9.2. Financial Performance
    • 15.9.3. Product Portfolio
    • 15.9.4. Strategic Initiatives
  • 15.10. Norbrook Laboratories Limited
    • 15.10.1. Company Overview
    • 15.10.2. Financial Performance
    • 15.10.3. Product Portfolio
    • 15.10.4. Strategic Initiatives
  • 15.11. Hester Biosciences Limited
    • 15.11.1. Company Overview
    • 15.11.2. Financial Performance
    • 15.11.3. Product Portfolio
    • 15.11.4. Strategic Initiatives
  • 15.12. Merial Animal Health Limited
    • 15.12.1. Company Overview
    • 15.12.2. Financial Performance
    • 15.12.3. Product Portfolio
    • 15.12.4. Strategic Initiatives
  • 15.13. Novartis Animal Health, Inc.
    • 15.13.1. Company Overview
    • 15.13.2. Financial Performance
    • 15.13.3. Product Portfolio
    • 15.13.4. Strategic Initiatives
  • 15.14. Nutreco N.V.
    • 15.14.1. Company Overview
    • 15.14.2. Financial Performance
    • 15.14.3. Product Portfolio
    • 15.14.4. Strategic Initiatives
  • 15.15. Ouro Fino SaAºde Animal
    • 15.15.1. Company Overview
    • 15.15.2. Financial Performance
    • 15.15.3. Product Portfolio
    • 15.15.4. Strategic Initiatives
  • 15.16. Other Notable Players
    • 15.16.1. Company Overview
    • 15.16.2. Financial Performance
    • 15.16.3. Product Portfolio
    • 15.16.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦